This week's top media moves include Teen Vogue's new style director, CEO shifts at Converse and Wolford, and more.

Kenvue Inc. (NYSE: KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s ...

Inventiva named Jason Campagna as president of R&D and chief medical officer, and Martine Zimmermann as EVP of regulatory affairs and quality assurance. Evolent named Dr. David Lim as chief clinical ...

Kenvue Inc. has announced a leadership change and the initiation of a strategic review aimed at optimizing its brand ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

New HHS contract reviews are delaying care and filling of vacancies, IHS insiders tell Stat News. Meanwhile, KFF Health News dives into rehabilitation hospitals.

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

Current Kenvue Director, Kirk Perry, is named Interim CEO, effective immediately. Kenvue Board of Directors appointed a new Interim CEO and is advancing an ongoing comprehensive review of strategic ...

“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Kirk Perry has been named interim CEO, effective immediately, as the board conducts a search for Mongon's permanent successor ...